Fact CheckerSign in

NCT04310826Active, not recruiting

Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy

Feasibility of Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Ovarian Cancer Patients Receiving Carboplatin Chemotherapy

Source: ClinicalTrials.gov · Last updated 21 Aug 2026

Brief summary (registry, in English)

This trial studies how well a diet high in magnesium works in preventing low blood magnesium levels (hypomagnesemia) in patients with ovarian cancer receiving carboplatin chemotherapy. Hypomagnesemia is a common side effect of carboplatin-containing chemotherapy. A magnesium rich diet may increase the levels of magnesium in the blood and help prevent hypomagnesemia resulting from carboplatin chemotherapy.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
26 (actual)
First submitted
13 Mar 2020
Start date
23 Apr 2019
Primary completion date
1 Apr 2028
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT04310826

What you commit to

  • Study type: Interventional
  • Participants enrolled: 26
  • From 23 Apr 2019 to the primary completion date, 1 Apr 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior platinum-based chemotherapy.

Lab values

  • Serum creatinine level \> 1.4 mg/dL prior to treatment.

Other

  • Artificial nutrition (e.g. Ensure or Boost) accounts for \> 50% of total calorie intake.

Who the study is looking for

  • Patients with previously untreated ovarian cancer.
  • Receiving carboplatin-containing chemotherapy of at least 6 consecutive cycles.
  • Able to tolerate an oral diet.

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.